Aegon, NL0000303709

Aegon Stock - New president, New York HQ and US redomiciliation

17.06.2026 - 17:38:26 | ad-hoc-news.de

Aegon reshapes its leadership and corporate structure, naming Will Fuller president and COO while planning a move of its legal seat to Delaware and a future headquarters in New York City, as the insurer prepares for its next phase of growth in the US market.

Aegon, NL0000303709
Aegon, NL0000303709

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 17:37 CET. Details in the imprint.

Aegon (NL0000303709) is restructuring its leadership and legal footprint while deepening its ties to the United States. Reuters reports that the insurer has appointed Will Fuller as president and chief operating officer and selected New York City as its future corporate headquarters as it prepares to shift its legal seat to Delaware.

Go deeper

All news and analysis on Aegon stock

Follow ongoing coverage of Aegon’s restructuring, US move and earnings developments on the dedicated topic page and the company’s own investor-relations hub.

New president and US headquarters

The latest strategic move centers on leadership and geography. According to a Reuters-based summary, life insurer Aegon has appointed Will Fuller as president and chief operating officer, with effect from January 1, 2027.

Fuller will oversee Transamerica, Aegon’s international businesses and Aegon Asset Management, reporting directly to CEO Lard Friese. Friese will remain responsible for group strategy and overall performance, giving Aegon a dual-leadership structure focused on execution and long-term direction.

At the same time, Aegon plans to relocate its future corporate headquarters to New York City. The company expects to open an office there in mid-2027 to host key corporate functions and members of the top leadership team.

The New York decision reflects Aegon’s long-standing focus on the US market through Transamerica. In parallel, the group intends to shift its legal seat from the Netherlands to the US state of Delaware as part of a broader reorganization.

Operational strategy and US redomiciliation

The leadership reshuffle is embedded in a wider operational strategy. Aegon outlined the planned redomiciliation in a Form 6-K filing, which highlights its intent to file a Form F-4 registration statement with the US Securities and Exchange Commission covering the move.

Under the plan, Aegon will seek shareholder approval for redomiciliation at an extraordinary general meeting, currently envisaged for the fourth quarter of 2026. The company also intends to rebrand as Aegon Ltd., aligning its name more closely with a US corporate structure.

Management frames the shift as a way to bring the group’s legal and governance center closer to its largest business, Transamerica. Aegon has previously highlighted the US as a key profit driver and source of scale in life insurance, retirement and investment products.

Analysts and investors will likely focus on execution risk around regulatory approvals, the timeline for the move to Delaware and practical questions such as tax implications and future capital management policies.

The product behind the stock

Aegon generates most of its earnings from life insurance, retirement and investment solutions sold under the Aegon and Transamerica brands. Core offerings include individual life insurance, workplace retirement plans, annuities and mutual-fund based investment products for retail and institutional clients.

Where the stock trades today

The shares of Aegon (NL0000303709) trade on Euronext Amsterdam under the ticker AGN at EUR 6.27 as of 06/17/2026, 17:15 CET.

Key facts on Aegon stock

  • Company: Aegon N.V.
  • ISIN: NL0000303709
  • WKN: 629944
  • Ticker: AGN
  • Venue: Euronext Amsterdam
  • Price (as of 06/17/2026, 17:15 CET): 6.27 EUR
  • Market cap: 12,500,000,000 EUR (as of 06/17/2026)
  • Sector / Industry: Financials / Life & Health Insurance
  • Index membership: Euro Stoxx 600
  • Next earnings date: 08/15/2026

More on Aegon stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | NL0000303709 | AEGON | boerse | 69564257 | bgmi